G. H. Schuring‐Blom

Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact

D. Oepkes, E. Sistermans, M. Weiss, 2016, Prenatal diagnosis.

TRIDENT-2: National Implementation of Genome-Wide Non-Invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.

D. Oepkes, D. Smeets, F. Jehee, 2019, American journal of human genetics.

Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non‐invasive prenatal testing?

M. P. Koster, K. Lichtenbelt, G. Page-Christiaens, 2015, Prenatal diagnosis.

Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study

E. Sistermans, B. Faas, K. Lichtenbelt, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trends in the utilization of invasive prenatal diagnosis in The Netherlands during 2000–2009

B. Alizadeh, P. Scheffer, K. Lichtenbelt, 2011, Prenatal diagnosis.

Does confined placental mosaicism account for adverse perinatal outcomes in IVF pregnancies?

M. Eijkemans, J. Laven, K. Lichtenbelt, 2008, Human reproduction.